Lymphoma, T-Cell, Cutaneous

IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers

Tissue Repository: CTCL Collection Protocol

Skin Barrier and Microbiome of CTCL Patients

A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin

Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)

VircapSeq Virus Detection in Sézary Syndrome

Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides

PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL)

A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)

A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL

AFM13 in Relapsed/Refractory Cutaneous Lymphomas

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042)

Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma

AEDV Registry of Primary Cutaneous Lymphoma

Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas

Study of Photopheresis in the Treatment of Erythrodermic MF and SS

Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders